SGD Pharma, Global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces the opening of a new siliconization operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant.
SGD Pharma, global primary glass packaging leader, has announced the appointment of Fabio Invernizzi as its new General Manager of its West BU.
SGD Pharma marked the start of the New Year by celebrating the renovation of its Saint-Quentin-Lamotte (SQLM) furnace No2 with a lighting ceremony performed by our appointed Godmother, Vanessa Rade, in accordance with glassmaking tradition.
SGD Pharma, announces its goal to become the global market leader in primary pharmaceutical glass packaging. CEO Olivier Rousseau explains that SGD Pharma intends to significantly grow in 2024, with a sustained and consistent approach to its commercial, innovation, industrial, sustainability, HR and M&A strategies.
We leverage continuous improvements
At SGD Pharma, we are committed to conducting our business in a sustainable and ethical manner. Our top priority is to accelerate the decarbonization of the products we deliver to our customers.
SGD Pharma contributes to satisfying our customers as well as to supporting sustainable development with a focus on three main axes :
As an industrial company, our top priority is the health and safety of our employees, a topic for which we have deployed a full system of policies, tools and processes. We also values individual development in our people.
We contribute to the UN Sustainable Development Goals :
We believe the way we conduct our business and build our relationships with all our stakeholders must be in line with the highest possible standards and must foster sustainable and ethical practices and principles within our value chain and our sphere of influence. As a member of the United Nations Global Compact, it is our duty is to share our commitment to the 10 principles and promote them both internally and externally.
We contribute to the UN Sustainable Development Goals :
We have set clear long-term objectives for minimizing environmental impact by reducing energy consumption and CO2 emissions, as well as optimizing water use, waste management and resource efficiency.
We contribute to the UN Sustainable Development Goals :
In a recent roundtable hosted by Pharma's Almanac, Olivier Rousseau, the Chief Executive Officer of SGD Pharma, shared his valuable perspectives on the latest developments within the pharmaceutical industry. In the face of today's challenges, Mr Rousseau, suggested how pharmaceutical glass packaging can help pharma companies navigate a renewed drive for sustainability.
